Pfizer Veteran Bourla to Take Over CEO Role From Ian Read
- Shares of drug giant outpaced S&P 500 during Read’s tenure
- Bourla has taken increasingly prominent role in recent years
This article is for subscribers only.
Pfizer Inc. Chief Executive Officer Ian Read plans to step aside after eight years at the helm of the U.S.’s biggest drugmaker, handing the role to a company veteran in a widely expected transition.
Albert Bourla, 56, who was appointed chief operating officer at the start of the year, will take over as CEO in January. Read, 65, will remain executive chairman, giving the longtime Pfizer head continuing oversight of the pharmaceutical giant.